The prenatal diagnosis of Down’s syndrome based on the biochemical screening of maternal serum markers

ISSN 0564-3783

Main page
Contacts
Themes
Archive

Themes
Subscription
Information to authors
Editorial board
Mobile version

Export citations
UNIMARC
BibTeX
RIS

The prenatal diagnosis of Down’s syndrome based on the biochemical screening of maternal serum markers

Arbuzova S.B., Nikolenko M.I., Khlevnaia L.A., Fedotova O.O., Solov’eva V.D., Malova S.A.

The role of maternal alpha-fetoprotein and cho c49 rionic gonadotprin screening in complex prenatal diagnosis of Down syndrome had been studied. The average markers’ values in cases of fetus trisomy 21 were 0.67 MoM (AFP) and 2.68 MoM (HGG). The correlative dependence between the markers’ levels in trisomy 21 and the date of testing have been found. The high efficiency of differentiative approach to invasive investigations in the older age group of pregnant (above 35 years old) on the basis of AFP and HGG screening has been established.

Tsitologiya i Genetika 1998, vol. 32, no. 1, pp. 66-71

Arbuzova S.B., Nikolenko M.I., Khlevnaia L.A., Fedotova O.O., Solov’eva V.D., Malova S.A. The prenatal diagnosis of Down’s syndrome based on the biochemical screening of maternal serum markers, Tsitol Genet., 1998, vol. 32, no. 1, pp. 66-71.

Coded & Designed by Volodymyr Duplij

Modified 23.09.23